The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Mirpresoc 40 mg Tablets

40 milligram(s) Tablet

Laboratorios LICONSA, S.A.PA1239/017/002

Main Information

Trade NameMirpresoc 40 mg Tablets
Active SubstancesTelmisartan
Strength40 milligram(s)
Dosage FormTablet
Licence HolderLaboratorios LICONSA, S.A.
Licence NumberPA1239/017/002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA07 telmisartan

Status

Authorised/WithdrawnAuthorised
Licence Issued26/11/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0049-004-014
Interchangeable List DocumentPDF of Interchangeable List
« Back